Han WR et al.Idarubicin-145-2C11-F(ab')2 promotes peripheral tolerance and reduces chronic vascular disease in mouse cardiac allografts.Transpl Immunol 7:207-13 (1999).
Kinnaert P et al.Role of CD18-dependent and CD18-independent mechanisms in the increased leukocyte adhesiveness and in the variations of circulating white blood cell populations induced by anti-CD3 monoclonal antibodies.Transpl Int 9:386-91 (1996).
Vossen AC et al.Fc receptor binding of anti-CD3 monoclonal antibodies is not essential for immunosuppression, but triggers cytokine-related side effects.Eur J Immunol 25:1492-6 (1995).
Henrickson M et al.Comparison of in vivo efficacy and mechanism of action of antimurine monoclonal antibodies directed against TCR alpha beta (H57-597) and CD3 (145-2C11).Transplantation 60:828-35 (1995).
Leo O et al.Identification of a monoclonal antibody specific for a murine T3 polypeptide.Proc Natl Acad Sci U S A 84:1374-8 (1987).
Samelson LE et al.T cell antigen receptor phosphorylation induced by an anti-receptor antibody.J Immunol 139:2708-14 (1987).